期刊
PHARMACOGENOMICS
卷 13, 期 2, 页码 179-184出版社
FUTURE MEDICINE LTD
DOI: 10.2217/PGS.11.146
关键词
CYP2D6; severity of suicide attempt; ultrarapid metabolizer
资金
- Spanish Ministry of Health Instituto de Salud Carlos III
- Junta de Extremadura
- EU-FEDER [PI10/02758, CP06/00030, BS10023]
- Conchita Rabago
- Harriet and Esteban Vicente Foundation
- National Alliance for Research on Schizophrenia and Affective Disorders (NARSAD) [FIS 01/00770-1, Rio Hortega CM08/00170]
Aim: Among people who die by suicide, an increased frequency of CYP2D6 active gene multiplication has been described. Therefore, the present study analyzed the relationship between the severity of the suicidal intent and CYP2D6 number of active genes among survivors. Materials & methods: A group of 342 individuals were evaluated with Beck Suicide Intent Scale within 24 h of the failed attempt. 'Severe' suicide attempters were classified as those scoring above percentile 75 in the objective circumstances section of the Suicide Intent Scale Scale. A group of 377 healthy controls were also genotyped. Results: A higher number of 'severe' suicide attempters carrying >= 2 active CYP2D6 genes as compared with the rest of the patients population (p < 0.01) or the healthy control group (p < 0.01) was found. Conclusion: Considering that 'severe' suicide attempters are more likely eventually to die by suicide, CYP2D6 genetic polymorphism might be of use as a biomarker of death by suicide, which is in agreement with previous findings. Original submitted: 17 July 2011; Revision submitted: 21 September 2011
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据